MERLYN SALMON: Open Payments
NPI 1912130246 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$680 in 33 payments from 11 companies in 2025. Trend: 2023 $63 · 2024 $437 · 2025 $680
Food & beverage: $680
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $157 |
| Exact Sciences Corporation | 5 | $107 |
| Lilly USA, LLC | 5 | $106 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49 |
| Amgen Inc. | 3 | $46 |
| Novo Nordisk Inc | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Eisai Inc. | 2 | $32 |
| PFIZER INC. | 1 | $27 |
Products named: The Cologuard Plus Collection Kit, FARXIGA, AIRSUPRA, MOUNJARO, Kerendia, JARDIANCE, KISUNLA, Ozempic.
Industry payments across FL — which companies pay providers there.
